| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/15/2009 | WO2008066810A3 Pleasant tasting dry powder compositions suitable for pulmonary delivery |
| 01/15/2009 | WO2008066755A3 Tyrosine kinase inhibitors as anti-kinetolastid and anti-apicomplexan agents |
| 01/15/2009 | WO2008064756A3 Use of substances reducing cellular glutathione content for producing a medicament for treating t-cell mediated autoimmune diseases |
| 01/15/2009 | WO2008063581A3 Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs |
| 01/15/2009 | WO2008060890A3 Darusentan oral dosage form |
| 01/15/2009 | WO2008049904A3 Use of mtki 1 for treating or preventing bone cancer |
| 01/15/2009 | WO2008035291A3 A double stranded rna oligonucleotide: a pharmaceutical or cosmetic composition containing it and its use as an active pharmaceutical ingredient in the treatment of androgen-related diseases |
| 01/15/2009 | WO2008021296A3 Compositions and methods for the treatment and prophylaxis of alzheimer's disease |
| 01/15/2009 | WO2008017598A3 Citrusal aroma receptors and use of myrac aldehyde derivatives for increasing the flagellation frequency of a spermatozoon |
| 01/15/2009 | WO2008011083A9 Compounds for enhancing arginase activity and methods of use thereof |
| 01/15/2009 | WO2008009426A9 5-cyano-prostacyclin derivatives as agents for the treatment of autoimmune diseases |
| 01/15/2009 | WO2007144143A8 Method for preparing polymeric matrices by radiation in the presence of sensitive pharmaceutical compounds |
| 01/15/2009 | WO2007119028A9 Composition including at least one aqueous phase and at least one fatty phase including ivermectin |
| 01/15/2009 | WO2007114827A8 Substituted heterocyclic compounds and methods of use |
| 01/15/2009 | WO2007075799A3 Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
| 01/15/2009 | WO2006073202A9 METHOD OF TUMOR SUPPRESSION AND EVALUATION OF ANTICANCER AGENT BASED ON GSK3β INHIBITORY EFFECT |
| 01/15/2009 | WO2006003222A9 Use of formoterol in the prophylactic and/or therapeutic treatment of muscle wasting and/or cachectic syndrome which are associated with catabolic conditions of certain diseases, such as cancer, aids, infections, diabetes and others |
| 01/15/2009 | WO2005087199A3 Stabilised supersaturated solid solutions of steroidal drugs |
| 01/15/2009 | US20090018809 Computer gene |
| 01/15/2009 | US20090018357 Compositions of phospholipid ether boronic acids and esters and methods for their synthesis and use |
| 01/15/2009 | US20090018342 New epothiolone derivatives, process for their production, and their pharmaceutical use |
| 01/15/2009 | US20090018338 Treatment of CRTH2-Mediated diseases and conditions |
| 01/15/2009 | US20090018335 Fused heterocyclic compound |
| 01/15/2009 | US20090018331 Condensed imidazole derivatives |
| 01/15/2009 | US20090018313 Using trisodium citrate wash as tool in recovering fibrinogin from cryo-solution; preparing fibrin fabric for use in surgery and as wound healing agent |
| 01/15/2009 | US20090018311 Methods and compounds for producing dipeptidyl peptidase iv inhibitors and intermediates thereof |
| 01/15/2009 | US20090018214 Composition for Promoting Vascular Smooth Muscle Relaxation |
| 01/15/2009 | US20090018213 Antiviral method |
| 01/15/2009 | US20090018212 Methods of relieving stress |
| 01/15/2009 | US20090018211 Method for inhibiting of COX2 and inflammation with phenolic aldehydes |
| 01/15/2009 | US20090018210 A Method for Promoting Fat Degradation |
| 01/15/2009 | US20090018209 Curcumin and curcuminoid inhibition of angiogenesis |
| 01/15/2009 | US20090018208 Novel Succinate Salt of O-Desmethyl-Venlafaxine |
| 01/15/2009 | US20090018207 Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity |
| 01/15/2009 | US20090018206 Prevention of hypotension and stabilization of blood pressure in hemodialysis patients |
| 01/15/2009 | US20090018205 Methods for treatment of migraine and symptoms thereof |
| 01/15/2009 | US20090018204 Composition and method for enhancing hair growth |
| 01/15/2009 | US20090018203 Modified release compositions of milnacipran |
| 01/15/2009 | US20090018202 Modafinil compositions |
| 01/15/2009 | US20090018200 Composition containing a phenanthrenol |
| 01/15/2009 | US20090018199 Methods of Administering 3, 3, 14, 14 Tetramethyl Hexadecane 1, 16 Dioic Acid |
| 01/15/2009 | US20090018198 Method for treating a motoneuron disorder |
| 01/15/2009 | US20090018197 Methods for treating status epilepticus and related conditions |
| 01/15/2009 | US20090018196 Food composition comprising amino acids |
| 01/15/2009 | US20090018193 Essential fatty acids in the prevention of cardiovascular events |
| 01/15/2009 | US20090018191 Deuterated Catecholamine Derivatives and Medicaments Comprising Said Compounds |
| 01/15/2009 | US20090018190 Compositions and Methods for Transdermal Oxybutynin Therapy |
| 01/15/2009 | US20090018189 Hormone Sensitive Lipase Modulators And Methods Of Use |
| 01/15/2009 | US20090018187 Strontium (M) ascorbate, compositions containing same, method for making same and method of using same |
| 01/15/2009 | US20090018186 Stable beverage products comprising polyunsaturated fatty acid emulsions |
| 01/15/2009 | US20090018185 Compositions and products containing s-equol, and methods for their making |
| 01/15/2009 | US20090018184 Polyether Brevetoxin Derivatives as a Treatment for Cystic Fibrosis, Mucociliary Dysfunction, and Pulmonary Diseases |
| 01/15/2009 | US20090018183 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 01/15/2009 | US20090018182 Crystalline forms of atorvastatin |
| 01/15/2009 | US20090018181 Drug composition for prevention or inhibition of advance of diabetic complication |
| 01/15/2009 | US20090018180 2-imidazolines |
| 01/15/2009 | US20090018179 Novel crystals and process of making 5-(-methyl)-2-methoxy-benzoic acid |
| 01/15/2009 | US20090018178 Use of haloarylpyrazole compounds in the control of parasite infestation on animals |
| 01/15/2009 | US20090018177 Propane-1,3-Dione Derivative or Salt Thereof |
| 01/15/2009 | US20090018175 Pharmaceutical excipient complex |
| 01/15/2009 | US20090018174 Macrolides as anti-inflammatory agents |
| 01/15/2009 | US20090018173 Method for controlling the yeast-to-filamentous growth transition in fungi |
| 01/15/2009 | US20090018172 DIPHENYLUREA DERIVATIVES AND THEIR USE AS CHLORIDE CHANNEL BLOCKERS OR BKCa CHANNEL MODULATORS |
| 01/15/2009 | US20090018171 Imidazole derivatives |
| 01/15/2009 | US20090018170 5-lipoxygenase-activating protein (flap) inhibitors |
| 01/15/2009 | US20090018169 Sulfonamide Derivatives for the Treatment of Bacterial Infections |
| 01/15/2009 | US20090018168 administering 5-(3-((1R,2R,3R,5R)-5-chloro-2-((3,5-dichlorophenylthio)methyl)-3-hydroxycyclopentyl)propyl)-thiophene-2-carboxylic acid to reduce intraocular pressure; treating glaucoma |
| 01/15/2009 | US20090018167 angiogenesis inhibitors such as 1-phenyl-3-pyridin-2-ylprop-2-en-1-one, having antitumor and anticarcinogenic activity; treatment of skin disorders such as psoriasis, acne, rosacea, warts, eczema, hemangiomas, and lymphangiogenesis, as well as chronic inflammatory disease such as arthritis |
| 01/15/2009 | US20090018166 New Pyridine Analogues X 161 |
| 01/15/2009 | US20090018165 Biphenyl compounds useful as muscarinic receptor antagonists |
| 01/15/2009 | US20090018164 Farnesyl protein transferase inhibitors for treating breast cancer |
| 01/15/2009 | US20090018163 Substituted Heterocyclic Ethers and Their Use in CNS Disorders |
| 01/15/2009 | US20090018162 Use of 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or salt thereof for treating retrovirus infection |
| 01/15/2009 | US20090018161 Method for promoting gastrointestinal function and method for screening for promoter of gastrointestinal function |
| 01/15/2009 | US20090018160 Heterocyclic Compounds with Affinity to Muscarinic Receptors |
| 01/15/2009 | US20090018159 Treatment of Diabetes |
| 01/15/2009 | US20090018158 Crystal forms of an imidazole derivative |
| 01/15/2009 | US20090018157 Chemical compounds |
| 01/15/2009 | US20090018156 Pyrrolo [2,3,B] Pyridine Derivatives Useful As RAF Kinase Inhibitors |
| 01/15/2009 | US20090018155 Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy |
| 01/15/2009 | US20090018154 Opioid and methods of making and using the same |
| 01/15/2009 | US20090018153 antiproliferative; cancer, psoriasis; increased bioavailability |
| 01/15/2009 | US20090018152 Aminophenyl Derivatives as Novel Inhibitors of Histone Deacetylase |
| 01/15/2009 | US20090018151 Topical Treatment of Peripheral diabetic complications |
| 01/15/2009 | US20090018150 5-Ht2b Receptor Antagonists |
| 01/15/2009 | US20090018149 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and methods for medical intervention against mycobacterial infections |
| 01/15/2009 | US20090018148 Xanthine Derivatives, Processes For Preparing Them And Their Uses |
| 01/15/2009 | US20090018147 Compounds for modulating TRPV3 function |
| 01/15/2009 | US20090018146 Combination Therapy with Triterpenoid Compounds and Proteasome Inhibitors |
| 01/15/2009 | US20090018145 Compositions and their use as anti-tumor agents |
| 01/15/2009 | US20090018144 Capped pyrazinoylguanidine sodium channel blockers |
| 01/15/2009 | US20090018143 Thio-substituted arylmethanesulfinyl derivatives |
| 01/15/2009 | US20090018142 Use of phosphatases to treat tumors overexpressing N-CoR |
| 01/15/2009 | US20090018141 Kinase inhibitors, compositions thereof, and methods of use therewith |
| 01/15/2009 | US20090018140 Thiazoles and oxazoles useful as modulators of atp-binding cassette transporters |
| 01/15/2009 | US20090018139 Treatment of CRTH2-mediated diseases and conditions |
| 01/15/2009 | US20090018138 Treatment of CRTH2-mediated diseases and conditions |
| 01/15/2009 | US20090018137 Buffer intracellular reduction and oxidation for the stressed cells in various disease states; beneficial as adjunctive support therapy, multiple chemical sensitivity syndrome, Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Roussy-Levy syndrome, Rosenberg Chutorian syndrome, Korsakoff syndrome |
| 01/15/2009 | US20090018136 Methods and compositions for the treatment of vascular disease |
| 01/15/2009 | US20090018135 Methods of treating bowel disorders |